Hexagon Bio
Hexagon Bio is seeking a Medicinal Chemistry Intern to participate in complex chemical syntheses and contribute to antibody-drug conjugate discovery programs. The internship offers hands-on laboratory experience, cross-disciplinary interaction, and mentorship from senior scientists in a dynamic, lab-based environment.
Hexagon Bio is a biotechnology company focused on developing novel payload mechanisms for antibody-drug conjugates (ADCs) to treat cancer. The company aims to overcome resistance to existing ADC payloads and expand ADC indications through its pipeline and scientific platform. Hexagon Bio operates in the biotech and oncology therapeutics industry.
Wilson Sonsini Advises Hexagon Bio on Multimillion-Dollar Joint Venture with Corteva
Dec 17, 2025
Corteva, Hexagon Bio Form Multi-Million Dollar JV to Power Next-Generation of Nature Inspired Solutions
Dec 16, 2025
Corteva, Hexagon Bio launch joint venture to develop crop protection
Dec 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Hexagon Bio.
32% above the average for this role
Hexagon Bio & Corteva Form JV to Advance Nature-Inspired Crop Protection
Dec 17, 2025
Medicinal Chemistry Intern
Neurocrine Biosciences
Medicinal Chemistry Intern
Roche
Director, Medicinal Chemistry, ADC Group Leader
Gilead Sciences
Principal Scientist, Medicinal Chemistry
lifelancer
Associate or Full Professor, Medicinal Chemistry
Indiana University
Associate Director, R&D Chemistry, Peptidomimetics
Regeneron Pharmaceuticals